Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1989-06-05
1992-10-20
Rotman, Alan L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514253, 514292, 544363, 546 87, 546146, 546147, 546169, A61K 3147, C07D40112
Patent
active
051570416
ABSTRACT:
Compounds of the formula ##STR1## wherein R.sup.1 is alkoxycarbonyl, aralkoxycarbonyl, alkanoyl, cycloalkylcarbonyl, aralkanoyl, aroyl, heterocyclylcarbonyl, alkylsulphonyl, arylsulphonyl, monoaralkylcarbamoyl, cinnamoyl or .alpha.-aralkoxycarbonylaminoalkanoyl and R.sup.2 is hydrogen or R.sup.1 and R.sup.2 together with the nitrogen atom to which they are attached represent a cyclic imide group of the formula ##STR2## in which P and Q together represent an aromatic system; R.sup.3 is alkyl, cycloalkyl, aryl, aralkyl, heterocyclylalkyl, cyanoalkyl, alkyl- sulphinylalkyl, carbamoylalkyl or alkoxycarbonylalkyl or, when n stands for zero, R.sup.3 can also represent alkylthioalkyl or, when n stands for 1, R.sup.3 can also represent alkylsulphonylalkyl; R.sup.4 is alkyl, cycloalkyl, cycloalkylalkyl, aryl or aralkyl; R.sup.5 is hydrogen and R.sup.6 is hydroxy or R.sup.5 and R.sup.6 together represent oxo; R.sup.7 and R.sup.8 together represent a trimethylene or tetramethylene group which is optionally substituted by hydroxy, alkoxycarbonylamino or acylamino or in which one --CH.sub.2 -- group is replaced by --NH--, --N(alkoxycar- bonyl)--, --N(alkyl)-- or --S-- or which carries a fused cycloalkane, aromatic or heteroaromatic ring; and R.sup.9 is alkoxycarbonyl, monoalkylcarbamoyl, monoaralkylcarbamoyl, monoarylcarbamoyl or a group of the formula ##STR3## in which R.sup.10 and R.sup.11 each represent alkyl; and their pharmaceutically acceptable acid addition salts inhibit proteases of viral origin and can be used as medicaments for the treatment or prophylaxis of viral infections. They can be manufactured according to generally known procedures.
REFERENCES:
patent: 4402969 (1983-09-01), Greenlee et al.
patent: 4470973 (1984-09-01), Natarajan et al.
patent: 4621092 (1986-11-01), Natarajan et al.
patent: 4636522 (1987-01-01), Gordon
patent: 4638010 (1987-01-01), Weller et al.
patent: 4720484 (1988-01-01), Vincent et al.
patent: 4812442 (1989-03-01), Boger et al.
patent: 4863905 (1989-09-01), Hadspeth et al.
patent: 4965250 (1990-10-01), Vincent et al.
Genetic Engineering & Biotechnology Monitor, No. 33, 30 (1991).
Chem. Eng. News, Apr. 30, 1990, p. 18.
C. S. Crumpacker, N. Engl. J. Med., 321:163-172 (1989).
J. Fuhrhop and G. Penzlin, Organic Sythesis: Concepts, Methods, Starting Materials, (Verlag Chemie, Weinheim, 1983), (textbook--no copy included).
M. Kotler et al., Proc. Natl. Acad. Sci. USA, 85:4185-89.
M. Miller et al., Nature, 337:576-79 (1989).
Meek et al., Nature, 343:90-92 (1990).
McQuade et al., Science, 247:454-456 (1990).
Dreyer et al., Proc. Natl. Acad. Sci., 86(24):9752-9756 (1989).
Jouin et al., J. Org. Chem., 54(3):617-627 (1989).
Fray et al., J. Org. Chem., 51(25):4828-4833 (1986).
Harris et al., Tetrahedron, 44(12):3489-3500 (1988).
Roberts et al., Science, 248:358-361 (1990).
Overton et al., Virology, 179:508-511 (1990).
Handa Balraj K.
Machin Peter J.
Martin Joseph A.
Redshaw Sally
Thomas Gareth J.
Epstein William H.
Gould George M.
Hoffmann-La Roche Inc.
Rocha Patricia S.
Rotman Alan L.
LandOfFree
Amino acid derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Amino acid derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Amino acid derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-192339